Back to News

2017-18 IQ Consortium Drug Product Pediatric Working Group Public Webinar Series

2017-18 IQ Consortium Drug Product Pediatric Working Group Public Webinar Series

May 1, 2018

The IQ Consortium’s Drug Product Pediatric Working Group would like to present to you a webinar series designed to advance pediatric formulation development through sharing of experiences, non-proprietary information and scientific excellence. This webinar series also serves as an online platform to promote pre-competitive interaction and collaboration among industry-peers.  We encourage you to share this with interested colleagues and remember, this is a public series - you do not need to be an IQ member to register for this webinar.  To access previous webinars in this series, click the link next to "WEBINAR ON DEMAND". 


Affiliation Date Webinar Title
John Morris Abbvie 14 September Development of Ritonavir Pediatric Formulations - WEBINAR ON DEMAND
Karen Thompson Merck 05 October Extemporaneous Formulations in Pediatric Drug Development - WEBINAR ON DEMAND
Matthew Santangelo Pfizer 02 November Immediate Release Reverse Enteric Coated Melt-Spray-Congeal Microspheres as a Pediatric Platform - WEBINAR ON DEMAND
Eleni Dokou Vertex 01 March CMC Considerations for Pediatric Drug DevelopmentWEBINAR ON DEMAND
David Clapham
Smita Salunke
EuPFI 05 April What is the EuPFI and What Can We Do for You?- WEBINAR ON DEMAND
Matthew Thomas Eli Lilly 03 May Container Closure and Device Systems for Pediatric Combination Products
Yogesh Patil Amgen 07 June Development of pediatric formulations: Consider Formulation and Regulatory Pitfalls
Daniel Schaufelberger Janssen 05 July TBC
Mike Bi Amgen 06 September Literature Review of Controlled-release Dosage Form Development for Pediatric Patient
Stuart Charlton BMS 04 October A Scientific and Risk Based Approach to Pediatric Formulations